Pidnarulex
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pidnarulex, covering 2026-04-13 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer [Phase 1, Phase 2]